Asia Pacific Sleep Aids market will grow by 8.5% annually with a total addressable market cap of $325,998.9 billion over 2022-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices.
Highlighted with 29 tables and 51 figures, this 117-page report "Asia Pacific Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Asia Pacific Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Smart Bedding
• Sleep Lab Services
• Sleep Apnea Devices
o Adaptive Servo-Ventilators (ASVs)
o Positive Airway Pressure (PAP) Devices
o Oral Appliances
o Facial Interfaces
o Other Sleep Apnea Devices
• Medication
o Prescription Drugs
o OTC Drugs
o Herbal Drugs
• Wearable Devices
• Other Product Types
Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Insomnia
• Sleep Apnea
• Narcolepsy
• Restless Leg Syndrome
• REM Sleep Behavior Disorder
• Sleepwalking
• Other Indications
By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Stores
• E-Commerce
• Hospital Pharmacies
• Retail Pharmacies
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Brain Monitoring Inc.
Apex Medical Corp.
Apnea Sciences Corporation
BMC Medical Co., Ltd.
Braebon Medical Corp.
Cadwell Industries Inc.
Cleveland Medical Devices Inc.
Compumedics Limited
Drive DeVilbiss Healthcare Inc.
Fisher & Paykel Healthcare Corp. Ltd.
GlaxoSmithKline plc
Itamer Medical Ltd.
Koninklijke Philips N. V.
Merck & Co., Inc.
Natus Medical Inc.
Nihon Kohden Corporation
Pfizer Inc.
ResMed Inc.
Sanofi S. A.
Sleep Number Corporation
SleepMed Inc.
SomnoMed Inc.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Product Type 40
3.1 Market Overview by Product Type 40
3.2 Smart Bedding 42
3.3 Sleep Lab Services 43
3.4 Sleep Apnea Devices 44
3.4.1 Adaptive Servo-Ventilators (ASVs) 46
3.4.2 Positive Airway Pressure (PAP) Devices 47
3.4.3 Oral Appliances 48
3.4.4 Facial Interfaces 49
3.4.5 Other Sleep Apnea Devices 50
3.5 Medication 51
3.5.1 Prescription Drugs 52
3.5.2 OTC Drugs 53
3.5.3 Herbal Drugs 54
3.6 Wearable Devices 55
3.7 Other Product Types 56
4 Segmentation of Asia Pacific Market by Indication 57
4.1 Market Overview by Indication 57
4.2 Insomnia 59
4.3 Sleep Apnea 60
4.4 Narcolepsy 61
4.5 Restless Leg Syndrome 62
4.6 REM Sleep Behavior Disorder 63
4.7 Sleepwalking 64
4.8 Other Indications 65
5 Segmentation of Asia Pacific Market by Distribution Channel 66
5.1 Market Overview by Distribution Channel 66
5.2 Drug Stores 68
5.3 E-Commerce 69
5.4 Hospital Pharmacies 70
5.5 Retail Pharmacies 71
6 Asia-Pacific Market 2021-2031 by Country 72
6.1 Overview of Asia-Pacific Market 72
6.2 Japan 75
6.3 China 78
6.4 Australia 81
6.5 India 83
6.6 South Korea 85
6.7 Rest of APAC Region 87
7 Competitive Landscape 89
7.1 Overview of Key Vendors 89
7.2 New Product Launch, Partnership, Investment, and M&A 92
7.3 Company Profiles 93
Advanced Brain Monitoring Inc. 93
Apex Medical Corp. 95
Apnea Sciences Corporation 96
BMC Medical Co., Ltd. 97
Braebon Medical Corp. 98
Cadwell Industries Inc. 99
Cleveland Medical Devices Inc. 100
Compumedics Limited 101
Drive DeVilbiss Healthcare Inc. 102
Fisher & Paykel Healthcare Corp. Ltd. 103
GlaxoSmithKline plc 104
Itamer Medical Ltd. 105
Koninklijke Philips N. V. 106
Merck & Co., Inc. 107
Natus Medical Inc. 108
Nihon Kohden Corporation 109
Pfizer Inc. 110
ResMed Inc. 111
Sanofi S. A. 112
Sleep Number Corporation 113
SleepMed Inc. 114
SomnoMed Inc. 115
Teva Pharmaceutical Industries Ltd. 116
RELATED REPORTS 117
Asia Pacific cutting tools market will grow by 6.0% annually with a total addressable market cap of $163.03 billion over 2024-2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for powe...
Asia Pacific paper machine clothing (PMC) market will grow by 5.3% annually with a total addressable market cap of $7.27 billion over 2024-2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking p...
Asia Pacific endoscopy devices market will grow by 7.7% annually with a total addressable market cap of $150.27 billion over 2024-2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic c...
Asia Pacific digital health and wellness market will grow by 20.8% annually with a total addressable market cap of $3,072.0 billion over 2024-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphon...
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Asia Pacific encoder market will grow by 10.6% annually with a total addressable market cap of $18.21 billion over 2024-2033. The growth is driven by the increased need for high-level automation across various industries, the surging demand for automobile and consumer electronics, and technological ...
Asia Pacific specialty coffee market will grow by 14.7% annually with a total addressable market cap of $266.39 billion over 2024-2033. The growth is driven by rising disposable income and urbanization, growing demand for on-the-go coffee, strengthening premium coffee shops, and rising preferences f...
Asia Pacific drone payload market will grow by 14.2% annually with a total addressable market cap of $67.15 billion over 2024-2033. The growth is driven by increasing applications of drones, rising defense investments in unmanned technologies, the development of advanced drone payload systems, incre...